Specify a stock or a cryptocurrency in the search bar to get a summary
Euroapi SAS
EAPIEuroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France. Address: 15 Rue Traversiere, Paris, France, 75012
Analytics
WallStreet Target Price
3.13 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures EAPI
Dividend Analytics EAPI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EAPI
Stock Valuation EAPI
Financials EAPI
Results | 2019 | Dynamics |